Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cannabis Corner: Health Canada Backlogs Risk Stalling Canadian Cannabis Research

Stockhouse Editorial
0 Comments| August 22, 2019

{{labelSign}}  Favorites
{{errorMessage}}

The Canadian federal government is scrambling to respond to a glut of license applications for cannabis research prompted by legalization in October 2018. The queue of applicants –there were 251 in line as of late July – and the attendant months-long waiting times are frustrating scientists interested in the basic biology and therapeutic possibilities of cannabis. The delays are also prompting criticism of Health Canada.

“Everybody is growing, consuming, and buying it, but the labs are still: ‘How do we get these projects going?’” says Jonathan Page, chief science officer for Aurora Cannabis in Edmonton, one of Canada’s licensed producers of the psychoactive plant. “The [licensing] system is swamped, and research is not exactly, I think, a priority.”

According to a University of Guelph researcher Mike Dixon, backlogs in permit processing at Health Canada have the potential to stall cannabis research throughout the country.

Article continues here.

Tags:

{{labelSign}}  Favorites
{{errorMessage}}